Newsletter Subject

Major Oversight by Bill Gates

From

outsiderclub.com

Email Address

newsletter@outsiderclub.com

Sent On

Tue, Dec 28, 2021 10:53 PM

Email Preheader Text

He just confessed a really big mistake... He just confessed a really big mistake... Outsider Club: B

He just confessed a really big mistake... He just confessed a really big mistake... Outsider Club: Because You'll Never Be on the Inside... [Outsider Club logo] Major Oversight by Bill Gates By Keith Kohl | December 28, 2021 - Baltimore, MD He just confessed a really big mistake... In a recent interview, Bill Gates admitted that the existing COVID-19 vaccines that the world poured billions of dollars into producing have failed to control infection and transmission. And then he made this astonishing statement... "We need a new way of doing vaccines." Wow. Bill Gates forced the vaccines upon the world... But now he says we need to approach them in an entirely different way. Talk about a major oversight. It just goes to show how "rich and smart people" can also be absolutely clueless. COVID isn’t some computer virus you can just wipe out with a program. It’s a biological one, and it’s become blatantly obvious that Bill Gates has no idea what he’s talking about. So what do we do now? Where does that leave the world? Big and small companies all over the globe are still working 24/7 to create a successful COVID treatment.And I've just found a company with a solution to COVID that could be better than any vaccine Bill Gates helped make possible... One that has nothing to do with needles. It’s actually a "COVID-killing" nasal spray. It’s easy to see why this is better than the COVID vaccines. For starters, there’s no fear or anxiety about getting stabbed with a needle. It also works FAST, making symptoms disappear within just seven days in early trials! Better still, scientists predict this spray could be effective against multiple COVID variants... As well as any new variants that pop up in the future. That’s why I believe this is going to be in every medicine cabinet in America. In fact, I fully expect this to become more common than aspirin! But the best part is the company behind this breakthrough is NOT some big pharma giant like Pfizer or Merck. It’s TINY, with a share price of less than $1. And it has the potential to end COVID once and for all. This could hand you the biggest biotech windfall of the decade... So I urge you to act while there’s still time. [Keep reading for more details.]( To your wealth, [Keith Kohl sig] Keith KohlInvestment Director, Topline Trader P.S. This nasal spray could be the breakthrough we’ve been waiting for to finally end the pandemic once and for all. It’s expected to be even BETTER than the vaccine, taking only seven days to kill the COVID virus and stop symptoms. FDA trials have already begun, and if it gets fast-track approval, this stock could rise by many multiples over the next several months. That’s why [I’m recommending this small biotech company for immediate purchase.]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here](, and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Outsider Club, please add newsletter@outsiderclub.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Outsider Club, Copyright © 2021, Outsider Club LLC and Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.](

Marketing emails from outsiderclub.com

View More
Sent On

08/12/2024

Sent On

06/12/2024

Sent On

04/12/2024

Sent On

03/12/2024

Sent On

02/12/2024

Sent On

26/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.